REFERENCES
1. Wessel DL. Managing low cardiac output syndrome after congenital heart surgery. Crit Care Med 2001;29:S220-30.
2. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-54.
3. Kozik DJ, Tweddell JS. Characterizing the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg 2006;81:S2347-54.
4. Aĝirbaşli M, Nguyen ML, Win K, et al. Inflammatory and hemostatic response to cardiopulmonary bypass in pediatric population: feasibility of seriological testing of multiple biomarkers. Artif Organs 2010;34:987-95.
5. Mcguinness J, Bouchier-hayes D, Redmond J. Understanding the inflammatory response to cardiac surgery. Surgeon 2008;6:162-71.
6. Ramaswamy V, Horton J, Vandermeer B, Buscemi N, Miller S, Yager J. Systematic review of biomarkers of brain injury in term neonatal encephalopathy. Pediatr Neurol 2009;40:215-26.
7. Epting CL, McBride ME, Wald EL, Costello JM. Pathophysiology of post-operative low cardiac output syndrome. Curr Vasc Pharmacol 2016;14:14-23.
8. Bautista-Hernandez V, Karamanlidis G, McCully JD, Del Nido PJ. Cellular and molecular mechanisms of low cardiac output syndrome after pediatric cardiac surgery. Curr Vasc Pharmacol 2016;14:5-13.
9. Parr GV, Blackstone EH, Kirklin JW. Cardiac performance and mortality early after intracardiac surgery in infants and young children. Circulation 1975;51:867-74.
10. Wernovsky G, Wypij D, Jonas RA, et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 1995;92:2226-35.
11. Hoffman TM, Wernovsky G, Atz AM, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003;107:996-1002.
12. Du X, Chen H, Song X, et al. Risk factors for low cardiac output syndrome in children with congenital heart disease undergoing cardiac surgery: a retrospective cohort study. BMC Pediatr 2020;20:87.
13. Ulate KP, Yanay O, Jeffries H, Baden H, Di Gennaro JL, Zimmerman J. An elevated low cardiac output syndrome score is associated with morbidity in infants after congenital heart surgery. Pediatr Crit Care Med 2017;18:26-33.
14. Roeleveld PP, de Klerk JCA. The perspective of the intensivist on inotropes and postoperative care following pediatric heart surgery: an international survey and systematic review of the literature. World J Pediatr Congenit Heart Surg 2018;9:10-21.
15. Loomba RS, Flores S. Use of vasoactive agents in postoperative pediatric cardiac patients: insights from a national database. Congenit Heart Dis 2019;14:1176-84.
16. Lechner E, Hofer A, Leitner-Peneder G, et al. Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: a pilot study. Pediatr Crit Care Med 2012;13:542-8.
17. Momeni M, Rubay J, Matta A, et al. Levosimendan in congenital cardiac surgery: a randomized, double-blind clinical trial. J Cardiothorac Vasc Anesth 2011;25:419-24.
18. Burkhardt BE, Rücker G, Stiller B. Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease. Cochrane Database Syst Rev 2015;3:CD009515.
19. Appelbaum A, Blackstone EH, Kouchoukos NT, Kirklin JW. Afterload reduction and cardiac output in infants early after intracardiac surgery. Am J Cardiol 1977;39:445-51.
20. Ranadive SM, Eugene AR, Dillon G, Nicholson WT, Joyner MJ. Comparison of the vasodilatory effects of sodium nitroprusside vs. nitroglycerin. J Appl Physiol (1985) 2017;123:402-6.
21. Stone ML, Kelly J, Mistry M, Buck M, Gangemi J, Vergales J. Use of nicardipine after cardiac operations is safe in children regardless of age. Ann Thorac Surg 2018;105:181-5.
22. Colucci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med 2000;343:246-53.
23. Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 2002;287:1531-40.
24. Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson K. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA 2005;293:1900-5.
25. Tweddell JS, Hoffman GM, Mussatto KA, et al. Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: lessons learned from 115 consecutive patients. Circulation 2002;106:I82-9.
26. Miller OI, Tang SF, Keech A, Pigott NB, Beller E, Celermajer DS. Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study. Lancet 2000;356:1464-9.
27. James C, Millar J, Horton S, Brizard C, Molesworth C, Butt W. Nitric oxide administration during paediatric cardiopulmonary bypass: a randomised controlled trial. Intensive Care Med 2016;42:1744-52.
28. Kirbas A, Yalcin Y, Tanrikulu N, Gürer O, Isik O. Comparison of inhaled nitric oxide and aerosolized iloprost in pulmonary hypertension in children with congenital heart surgery. Cardiol J 2012;19:387-94.
29. Wong J, Loomba RS, Evey L, Bronicki RA, Flores S. Postoperative inhaled nitric oxide does not decrease length of stay in pediatric cardiac surgery admissions. Pediatr Cardiol 2019;40:1559-68.
30. Smith HA, Canter JA, Christian KG, et al. Nitric oxide precursors and congenital heart surgery: a randomized controlled trial of oral citrulline. J Thorac Cardiovasc Surg 2006;132:58-65.
31. Bizzarro M, Gross I, Barbosa FT. Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease. Cochrane Database Syst Rev 2014:CD005055.
32. Schlapbach LJ, Horton SB, Long DA, et al. NITRIC Study Group, the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG), the Paediatric Critical Care Research group (PCCRG) and the ANZICS Paediatric Study Group (PSG). Study protocol: NITric oxide during cardiopulmonary bypass to improve Recovery in Infants with Congenital heart defects (NITRIC trial): a randomised controlled trial. BMJ Open 2019;9:e026664.
33. Graham EM, Atz AM, Butts RJ, et al. Standardized preoperative corticosteroid treatment in neonates undergoing cardiac surgery: results from a randomized trial. J Thorac Cardiovasc Surg 2011;142:1523-9.
34. Shore S, Nelson DP, Pearl JM, et al. Usefulness of corticosteroid therapy in decreasing epinephrine requirements in critically ill infants with congenital heart disease. Am J Cardiol 2001;88:591-4.
35. Hall RI, Smith MS, Rocker G. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg 1997;85:766-82.
36. Li Y, Luo Q, Wu X, Jia Y, Yan F. Perioperative corticosteroid therapy in children undergoing cardiac surgery: a systematic review and meta-analysis. Front Pediatr 2020;8:350.
37. Graham EM, Martin RH, Buckley JR, et al. Corticosteroid therapy in neonates undergoing cardiopulmonary bypass: randomized controlled trial. J Am Coll Cardiol 2019;74:659-68.
38. Flores S, FitzGerald MR, Iliopoulos I, et al. An international survey of corticosteroid use for the management of low cardiac output syndrome. Pediatr Crit Care Med 2017;18:630-7.
39. Hill KD, Baldwin HS, Bichel DP, et al. STRESS Network Investigators. Rationale and design of the STeroids to REduce Systemic inflammation after infant heart Surgery (STRESS) trial. Am Heart J 2020;220:192-202.
40. Bettendorf M, Schmidt KG, Tiefenbacher U, Grulich-Henn J, Heinrich UE, Schönberg DK. Transient secondary hypothyroidism in children after cardiac surgery. Pediatr Res 1997;41:375-9.
41. Mackie AS, Booth KL, Newburger JW, et al. A randomized, double-blind, placebo-controlled pilot trial of triiodothyronine in neonatal heart surgery. J Thorac Cardiovasc Surg 2005;130:810-6.
42. Marwali EM, Caesa P, Darmaputri S, et al. Oral Triiodothyronine supplementation decreases low cardiac output syndrome after pediatric cardiac surgery. Pediatr Cardiol 2019;40:1238-46.
43. Portman MA, Slee A, Olson AK, et al. TRICC Investigators. Triiodothyronine supplementation in infants and children undergoing cardiopulmonary bypass (TRICC): a multicenter placebo-controlled randomized trial: age analysis. Circulation 2010;122:S224-33.
44. Marwali EM, Boom CE, Budiwardhana N, et al. Oral triiodothyronine for infants and children undergoing cardiopulmonary bypass. Ann Thorac Surg 2017;104:688-95.
45. Flores S, Loomba RS, Checchia PA, Graham EM, Bronicki RA. Thyroid hormone (triiodothyronine) therapy in children after congenital heart surgery: a meta-analysis. Semin Thorac Cardiovasc Surg 2020;32:87-95.
46. Alten JA, Borasino S, Toms R, Law MA, Moellinger A, Dabal RJ. Early initiation of arginine vasopressin infusion in neonates after complex cardiac surgery. Pediatr Crit Care Med 2012;13:300-4.
47. Bigelow AM, Ghanayem NS, Thompson NE, et al. Safety and efficacy of vasopressin after fontan completion: a randomized pilot study. Ann Thorac Surg 2019;108:1865-74.
48. Rizza A, Bignami E, Belletti A, et al. Vasoactive Drugs and hemodynamic monitoring in pediatric cardiac intensive care: an italian survey. World J Pediatr Congenit Heart Surg 2016;7:25-31.
49. Yuerek M, Rossano JW, Mascio CE, Shaddy RE. Postoperative management of heart failure in pediatric patients. Expert Rev Cardiovasc Ther 2016;14:201-15.
50. Mascio CE, Austin EH 3rd, Jacobs JP, et al. Perioperative mechanical circulatory support in children: an analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database. J Thorac Cardiovasc Surg 2014;147:658-64: discussion 664-5.
